Biolife Solutions BLFS
NASDAQ BLFS
$37.30 +0.52 (+1.41%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biolife Solutions (BLFS) Liabilities from Discontinued Operations (2023 - 2024)

Updated

Biolife Solutions' Liabilities from Discontinued Operations was $78,000 in Q4 2024, down 98.8% from $6.5 million a year earlier.

Analysis

Biolife Solutions (BLFS) Liabilities from Discontinued Operations (2023 - 2024) Analysis & Trends

  • In earlier years, Liabilities from Discontinued Operations was $6.5 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Biolife Solutions 1.90 Bn 1.57 Bn 18.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 78,000.00
Dec 31, 2023 6.50 Mn
API Access

Biolife Solutions Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=BLFS&period=max&api_key=YOUR_API_KEY